Suraksha Diagnostic Ltd (SURAKSHA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Suraksha Diagnostic Ltd reported sales of ₹88 Cr, operating profit of ₹30 Cr (OPM 35%) and net profit of ₹13 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
SURAKSHA quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 67 60 65 73 79 78 81 88 Expenses 44 41 46 49 55 55 57 57 Operating Profit 23 18 19 24 24 23 24 30 OPM 35% 31% 29% 33% 31% 30% 30% 35% Other Income 1 1 1 1 1 1 1 1 Interest 2 2 2 3 3 3 4 4 Depreciation 9 9 9 9 10 11 11 11 Profit before tax 14 8 9 12 12 10 10 17 Tax 26% 26% 22% 26% 27% 28% 38% 22% Net Profit 10 6 7 9 9 7 6 13 EPS in Rs 2.4 1.18 1.42 1.8 1.73 1.44 1.21 2.5
SURAKSHA profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 223 190 219 252 310 325 Expenses 174 143 146 170 215 223 Operating Profit 49 47 73 82 95 102 OPM 22% 25% 33% 33% 31% 31% Other Income 1 1 1 4 3 3 Interest 2 10 10 9 13 14 Depreciation 15 32 33 35 41 43 Profit before tax 33 7 31 41 45 49 Tax 28% 10% 26% 25% 30% - Net Profit 24 6 23 31 31 35 EPS in Rs 344.2 94.49 342.46 6.11 6.18 6.88 Dividend Payout 0% 0% 0% 0% 8% -
SURAKSHA balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 7 7 10 - 10 Reserves 147 171 201 - 234 Borrowings 99 92 89 - 130 Other Liabilities 28 30 33 - 73 Total Liabilities 281 300 334 - 448 Fixed Assets 195 212 223 - 316 CWIP 2 1 11 - 35 Investments 0 0 1 - 0 Other Assets 84 87 99 - 97 Total Assets 281 300 334 - 448
SURAKSHA cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 42 44 60 63 82 Cash from Investing Activity -44 -21 -35 -40 -52 Cash from Financing Activity 1 -24 -25 -24 -29 Net Cash Flow 0 -1 0 0 1 Free Cash Flow 23 32 18 21 15 CFO/OP 95% 109% 95% 90% 100%
SURAKSHA ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 12 9 15 20 27 Inventory Days 38 82 89 100 81 Days Payable 84 187 193 169 209 Cash Conversion Cycle -34 -96 -89 -49 -101 Working Capital Days -15 -49 -37 -23 -28 ROCE 24% 9% 17% 18% 17%